QIAGEN NV's ticker is QGEN and the CUSIP is N72482123. A total of 217 filers reported holding QIAGEN NV in Q3 2017. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $772,584,000 | – | 16,639 | +11.8% | 0.44% | – |
Q1 2022 | $0 | – | 14,886 | -47.9% | 0.00% | – |
Q4 2021 | $0 | -100.0% | 28,548 | -47.3% | 0.00% | – |
Q3 2021 | $1,000 | – | 54,157 | +53.3% | 0.00% | – |
Q2 2021 | $0 | -100.0% | 35,328 | -9.7% | 0.00% | -100.0% |
Q1 2021 | $1,091,671,000 | -12.4% | 39,103 | -8.4% | 0.31% | -15.0% |
Q4 2020 | $1,246,815,000 | -40.5% | 42,673 | -43.2% | 0.37% | -39.4% |
Q3 2020 | $2,093,753,000 | +451.7% | 75,105 | +427.6% | 0.61% | +500.0% |
Q2 2020 | $379,537,000 | +1046.4% | 14,234 | +344.8% | 0.10% | +1583.3% |
Q3 2018 | $33,107,000 | -70.5% | 3,200 | -11.1% | 0.01% | -66.7% |
Q2 2018 | $112,056,000 | +635.8% | 3,600 | +599.0% | 0.02% | +500.0% |
Q1 2018 | $15,229,000 | -91.7% | 515 | -89.9% | 0.00% | -90.6% |
Q4 2017 | $183,193,000 | +135.5% | 5,105 | +297.3% | 0.03% | +113.3% |
Q3 2017 | $77,790,000 | -94.5% | 1,285 | -97.0% | 0.02% | -95.0% |
Q2 2017 | $1,405,289,000 | -41.8% | 42,563 | -48.7% | 0.30% | -44.7% |
Q1 2017 | $2,412,966,000 | – | 82,944 | – | 0.55% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kite Lake Capital Management (UK) LLP | 1,080,000 | $52,585,000 | 33.78% |
SYCOMORE ASSET MANAGEMENT | 430,536 | $20,822,000 | 4.03% |
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 8,215,122 | $397,895,000 | 3.96% |
Grandeur Peak Global Advisors, LLC | 834,208 | $40,618,000 | 2.21% |
Premier Fund Managers Ltd | 1,109,129 | $53,325,000 | 2.06% |
Eversept Partners, LP | 454,721 | $22,140,365 | 1.66% |
Chescapmanager LLC | 280,000 | $13,633,000 | 1.45% |
HealthCor Management, L.P. | 838,414 | $40,822,000 | 1.44% |
Bank of Italy | 591,025 | $28,599,000 | 1.30% |
swisspartners Ltd. | 31,000 | $1,503,000 | 1.22% |